TET2 and DNMT3A mutations in human T-cell lymphoma - PubMed (original) (raw)

TET2 and DNMT3A mutations in human T-cell lymphoma

Lucile Couronné et al. N Engl J Med. 2012.

No abstract available

PubMed Disclaimer

Similar articles

• Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case.
  Nguyen TB, Sakata-Yanagimoto M, Nakamoto-Matsubara R, Enami T, Ito Y, Kobayashi T, Obara N, Hasegawa Y, Chiba S. Nguyen TB, et al. Ann Hematol. 2015 Jul;94(7):1221-3. doi: 10.1007/s00277-015-2332-0. Epub 2015 Feb 17. Ann Hematol. 2015. PMID: 25687841 No abstract available.
• Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
  Ponciano-Gómez A, Martínez-Tovar A, Vela-Ojeda J, Olarte-Carrillo I, Centeno-Cruz F, Garrido E. Ponciano-Gómez A, et al. Tumour Biol. 2017 Oct;39(10):1010428317732181. doi: 10.1177/1010428317732181. Tumour Biol. 2017. PMID: 28992762
• A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
  Fernandez-Pol S, Ma L, Joshi RP, Arber DA. Fernandez-Pol S, et al. Appl Immunohistochem Mol Morphol. 2019 Jul;27(6):416-422. doi: 10.1097/PAI.0000000000000644. Appl Immunohistochem Mol Morphol. 2019. PMID: 29629950
• Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
  Fukumoto K, Nguyen TB, Chiba S, Sakata-Yanagimoto M. Fukumoto K, et al. Cancer Sci. 2018 Mar;109(3):490-496. doi: 10.1111/cas.13393. Epub 2017 Nov 27. Cancer Sci. 2018. PMID: 28889481 Free PMC article. Review.
• Clinical implications of novel mutations in epigenetic modifiers in AML.
  Abdel-Wahab O, Patel J, Levine RL. Abdel-Wahab O, et al. Hematol Oncol Clin North Am. 2011 Dec;25(6):1119-33. doi: 10.1016/j.hoc.2011.09.013. Epub 2011 Oct 29. Hematol Oncol Clin North Am. 2011. PMID: 22093580 Review.

Cited by

• Detection and Characterization of Clonal Hematopoiesis.
  Locher BN, Löwe P, Christen F, Damm F. Locher BN, et al. Methods Mol Biol. 2025;2865:449-474. doi: 10.1007/978-1-0716-4188-0_20. Methods Mol Biol. 2025. PMID: 39424737
• The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level.
  Davletgildeeva AT, Kuznetsov NA. Davletgildeeva AT, et al. Biomolecules. 2024 Sep 4;14(9):1117. doi: 10.3390/biom14091117. Biomolecules. 2024. PMID: 39334883 Free PMC article. Review.
• Perturbing TET2 condensation promotes aberrant genome-wide DNA methylation and curtails leukaemia cell growth.
  Guo L, Hong T, Lee YT, Hu X, Pan G, Zhao R, Yang Y, Yang J, Cai X, Rivera L, Liang J, Wang R, Dou Y, Kodali S, Li W, Han L, Di Stefano B, Zhou Y, Li J, Huang Y. Guo L, et al. Nat Cell Biol. 2024 Sep 9. doi: 10.1038/s41556-024-01496-7. Online ahead of print. Nat Cell Biol. 2024. PMID: 39251719
• Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology.
  Tan WY, Nagabhyrava S, Ang-Olson O, Das P, Ladel L, Sailo B, He L, Sharma A, Ahuja N. Tan WY, et al. Curr Issues Mol Biol. 2024 Jun 27;46(7):6533-6565. doi: 10.3390/cimb46070390. Curr Issues Mol Biol. 2024. PMID: 39057032 Free PMC article. Review.
• Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma.
  Witzig T, Sokol L, Kim WS, de la Cruz Vicente F, Martín García-Sancho A, Advani R, Roncero Vidal JM, de Oña Navarrete R, Marín-Niebla A, Rodriguez Izquierdo A, Terol MJ, Domingo-Domenech E, Saunders A, Bendris N, Mackey J, Leoni M, Foss F. Witzig T, et al. Blood Adv. 2024 Sep 10;8(17):4581-4592. doi: 10.1182/bloodadvances.2024012806. Blood Adv. 2024. PMID: 38991123 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations